Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Tracking John Paulson's Paulson & Company Portfolio - Q3 2016 Update
Hedge Funds

Tracking John Paulson's Paulson & Company Portfolio - Q3 2016 Update

by seekingalpha.com posted 1year ago 1270 views
This quarter, Paulson's US long portfolio decreased ~6% from $9.84B to $9.23B. There are 94 13F securities in the portfolio, although only 31 of them are significantly large equity holdings (more than 0.5% of the US long portfolio). The article is focused on the larger holdings. The top five positions are Allergan plc, Shire plc, Mylan NV, Teva Pharmaceuticals, and the SPDR Gold ETF. They together account for ~44% of the entire portfolio. The largest holding is Allergan plc at 10.25% of the portfolio.

In this article